Stay updated with breaking news from Sciences Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mirae Asset Global Investments Co. Ltd. raised its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 19.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 112,740 shares of the medical research company’s stock after buying an additional 18,357 shares during the quarter. Mirae Asset Global […]
AGF Investments Inc. increased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 87.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,862 shares of the biopharmaceutical company’s stock after acquiring an additional 2,262 shares during the period. AGF Investments […]
Kavar Capital Partners Group LLC lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 86.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,930 shares of the biopharmaceutical company’s stock after selling 17,995 shares during the quarter. Kavar Capital Partners Group […]
TCW Group Inc. boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 3.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 699,145 shares of the biopharmaceutical company’s stock after purchasing an additional 25,768 shares during the quarter. TCW Group […]
Tokio Marine Asset Management Co. Ltd. lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 1.4% during the 4th quarter, HoldingsChannel reports. The fund owned 18,959 shares of the biopharmaceutical company’s stock after buying an additional 255 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Gilead Sciences were […]